Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
Here’s what you may have missed over the last week:
Sunderstorm Acquires Lime to Expand House of Brands Into Pre-Rolls
Sunderstorm announced the acquisition of California pre-roll brand Lime, marking a strategic expansion into one of cannabis’s largest and most competitive product categories. The move builds on the company’s established strength in edibles and vapes under the KANHA banner, extending its “house of brands” model into a format that continues to drive volume and daily consumer engagement. Lime, founded in 2019, has built credibility through craftsmanship, strong retail velocity, and accessible pricing across hundreds of licensed California dispensaries.
The acquisition reflects a broader industry pivot toward disciplined growth, operational efficiency, and portfolio diversification rather than headline-driven expansion. Lime will continue to operate as a distinct brand while gaining access to Sunderstorm’s scaled manufacturing, enterprise systems, and quality infrastructure, positioning it for accelerated growth in California and eventual national markets.
Congress Moves to Continue Blocking Recreational Cannabis Sales in Washington, D.C.
Despite growing national momentum toward cannabis reform, Congress is again advancing measures that would prevent Washington, D.C., from establishing a regulated adult-use cannabis market. Lawmakers are pushing to maintain long-standing budget riders that block the District from using its own tax revenue to legalize and regulate recreational sales, reinforcing federal oversight even as states continue to chart independent paths.
The move highlights a persistent contradiction in U.S. cannabis policy, where local voter initiatives and city leadership remain constrained by congressional authority. Advocates argue the restriction undermines home rule and perpetuates an unregulated gray market, while opponents frame it as a public safety and federal jurisdiction issue.
Curaleaf Signals Strategic Shift With Proposed Domestication to Delaware
Curaleaf filed plans to domesticate its corporate structure in Delaware, a move that reflects growing emphasis on governance flexibility, tax efficiency, and long-term regulatory positioning among multi-state operators. Delaware’s corporate framework is widely viewed as favorable for complex, multi-jurisdictional businesses, particularly those navigating evolving federal cannabis rules.
The proposed change does not affect Curaleaf’s day-to-day operations but underscores how large operators are quietly preparing for a post-rescheduling landscape. As federal reform inches forward, corporate restructuring is becoming an increasingly common tool for MSOs looking to streamline compliance and prepare for broader capital market participation.
Cannabis Stocks Cool as Rescheduling Optimism Meets Market Reality
Cannabis equities delivered a mixed performance this week as early optimism around federal rescheduling encountered the slower pace of policy implementation. Tilray, one of the sector’s most closely watched stocks, saw gains tied to reform speculation soften following earnings and tempered guidance, highlighting investor caution amid persistent structural challenges.
While the prospect of relief from IRS Section 280E remains a major catalyst, analysts continue to stress that rescheduling alone will not resolve pricing pressure, oversupply, or fragmented state markets. The market response underscores a broader recalibration in cannabis investing, where execution and balance sheets are increasingly valued over reform headlines. Barron’s examined the trend in its latest market analysis.
